Clinical Trial

Prognosis and Risk Factors for Acute Kidney Injury

Recruiting
View on ClinicalTrials.gov →
Summary
The aim of our study is to analyze the accurate diagnosis and prognosis of acute kidney injury (AKI) based on its severity and to define long-term clinical and socioeconomic outcomes. Investigators defined the AKI group among adults aged 20 years or older who visited enrolled center and underwent at least two blood tests, including serum creatinine, within an interval of 7 days or less and a control group was matched 1:1 to the AKI group based on age, sex, year of visit, and baseline kidney function, forming the study population. Investigators then collected and analyzed various clinical, laboratory, and hospitalization records including demographic data, anthropometric data, laboratory data, and medical history.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-20.
Trial Details
NCT Number NCT06898944
Lead Sponsor Seoul National University Hospital
Collaborators: Seoul National University Bundang Hospital, SMG-SNU Boramae Medical Center, Keimyung University Dongsan Medical Center
Conditions Acute Kidney Injury
Enrollment 320,000 participants
Start Date 2022-08-22
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-02